Cocrystal Pharma Inc. Stock
Price
Target price
?
?
2.910%
0.025
2.910%
€5.96
07:31 / Stuttgart Stock Exchange
WKN: A3DWYX / Symbol: COCP / Name: Cocrystal Pharma / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Cocrystal Pharma Inc. Stock
Cocrystal Pharma Inc. gained 2.910% today.
The community is currently still undecided about Cocrystal Pharma Inc. with 2 Buy predictions and 0 Sell predictions.
With a target price of 5 € there is potential for a 464.97% increase which would mean more than doubling the current price of 0.89 € for Cocrystal Pharma Inc..
Our community identified positive and negative aspects for Cocrystal Pharma Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Cocrystal Pharma Inc. stock. On the other hand our users think that "Innovation" could be a problem in the future.
Pros and Cons of Cocrystal Pharma Inc. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cocrystal Pharma Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cocrystal Pharma Inc. | 2.910% | -3.911% | 0.000% | -50.575% | -70.345% | -68.089% | -94.691% |
| Pacira Pharmaceuticals | 1.980% | 1.000% | 12.849% | 13.483% | 9.189% | -53.670% | -58.264% |
| Rockwell Medical Inc. | -7.730% | 3.154% | -3.416% | -58.916% | -58.631% | -9.838% | -92.418% |
| Twist Bioscience Corp | -0.940% | 7.737% | 5.966% | -44.491% | -39.405% | 11.129% | -76.316% |
Comments
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its price target lowered by analysts at HC Wainwright from $7.00 to $6.00. They now have a "buy" rating on the stock.
Show more
Ratings data for COCP provided by MarketBeat
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Show more
Ratings data for COCP provided by MarketBeat
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its price target lowered by analysts at HC Wainwright from $10.00 to $7.00. They now have a "buy" rating on the stock.
Show more
Ratings data for COCP provided by MarketBeat